Stepan (SCL)
(Delayed Data from NYSE)
$79.24 USD
-1.84 (-2.27%)
Updated Nov 7, 2024 04:00 PM ET
After-Market: $79.41 +0.17 (0.21%) 7:58 PM ET
4-Sell of 5 4
B Value A Growth C Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$79.24 USD
-1.84 (-2.27%)
Updated Nov 7, 2024 04:00 PM ET
After-Market: $79.41 +0.17 (0.21%) 7:58 PM ET
4-Sell of 5 4
B Value A Growth C Momentum A VGM
Zacks News
Analysts Estimate Tronox (TROX) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Tronox (TROX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Analysts Estimate Stepan Co. (SCL) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Stepan Co. (SCL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Stepan Co. (SCL) Q4 Earnings Beat Estimates
by Zacks Equity Research
Stepan Co. (SCL) delivered earnings and revenue surprises of 9.26% and 0.04%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Nutrien (NTR) Lags Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Nutrien (NTR) delivered earnings and revenue surprises of -23.19% and 0.21%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: Stepan Co. (SCL) Q4 Earnings Expected to Decline
by Zacks Equity Research
Stepan Co. (SCL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Stepan Co. (SCL) is an Incredible Growth Stock: 3 Reasons Why
by Zacks Equity Research
Stepan Co. (SCL) could produce exceptional returns because of its solid growth attributes.
Stepan Co. (SCL) Q3 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Stepan Co. (SCL) delivered earnings and revenue surprises of 24.84% and 8.23%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: Dow Inc. (DOW) Q3 Earnings Expected to Decline
by Zacks Equity Research
Dow Inc. (DOW) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Stepan Co. (SCL) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Stepan Co. (SCL) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Stepan Co. (SCL) Beats Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Stepan Co. (SCL) delivered earnings and revenue surprises of 21.05% and 8.56%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Stepan Co. (SCL) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Stepan Co. (SCL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Stepan Co. (SCL) Moves 4.1% Higher: Will This Strength Last?
by Zacks Equity Research
Stepan Co. (SCL) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Can Value Investors Pick Stepan Company (SCL) Stock Now?
by Zacks Equity Research
Is Stepan Company (SCL) a great pick from the value investor's perspective right now? Read on to know more.
Stepan Co. (SCL) Q1 Earnings and Revenues Top Estimates
by Zacks Equity Research
Stepan Co. (SCL) delivered earnings and revenue surprises of 34.35% and 8.90%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Stepan Co. (SCL) Q4 Earnings Lag Estimates
by Zacks Equity Research
Stepan Co. (SCL) delivered earnings and revenue surprises of -3.96% and 9.36%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Albemarle (ALB) Beats Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Albemarle (ALB) delivered earnings and revenue surprises of 5.21% and 1.13%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Huntsman (HUN) Beats Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Huntsman (HUN) delivered earnings and revenue surprises of 7.95% and 3.38%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: Stepan Co. (SCL) Q4 Earnings Expected to Decline
by Zacks Equity Research
Stepan Co. (SCL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
DuPont de Nemours (DD) Tops Q4 Earnings and Revenue Estimates
by Zacks Equity Research
DuPont de Nemours (DD) delivered earnings and revenue surprises of 6.93% and 8.24%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
4 Stocks to Buy From the Prospering Diversified Chemical Industry
by Anindya Barman
An upswing in demand in major end markets from the pandemic-led downturn should enable the Zacks Chemicals Diversified industry to thrive. ALB, TROX, SCL and KRO are set to gain from the favorable industry fundamentals and strategic actions.
Stepan Co. (SCL) Tops Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Stepan Co. (SCL) delivered earnings and revenue surprises of 12.95% and 10.66%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate Stepan Co. (SCL) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Stepan Co. (SCL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Stepan Co. (SCL) Misses Q2 Earnings Estimates
by Zacks Equity Research
Stepan Co. (SCL) delivered earnings and revenue surprises of -1.63% and 9.18%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Stepan Co. (SCL) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Stepan Co. (SCL) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Choose These 5 Low Leverage Stocks to Avoid Debt-Related Risk
by Aparajita Dutta
A risk-averse investor should buy stocks that bear low leverage since a debt-free corporation is rare to find. You may consider buying IMO, SCL, PIPR, DQ, and TRGP.